tradingkey.logo

908 Devices Inc.

MASS
5.930USD
+0.090+1.54%
收盤 12/22, 16:00美東報價延遲15分鐘
214.18M總市值
虧損本益比TTM

908 Devices Inc.

5.930
+0.090+1.54%

關於 908 Devices Inc. 公司

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

908 Devices Inc.簡介

公司代碼MASS
公司名稱908 Devices Inc.
上市日期Dec 18, 2020
CEOKnopp (Kevin J)
員工數量246
證券類型Ordinary Share
年結日Dec 18
公司地址44 Third Avenue
城市BURLINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01803
電話19787294478
網址https://908devices.com/
公司代碼MASS
上市日期Dec 18, 2020
CEOKnopp (Kevin J)

908 Devices Inc.公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Dr. Brandi C. Vann, Ph.D.
Dr. Brandi C. Vann, Ph.D.
Independent Director
Independent Director
--
--
Jon Frattaroli
Jon Frattaroli
Vice President - Strategy
Vice President - Strategy
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Barbara Russo
Ms. Barbara Russo
Vice President - Marketing and Corporate Communications
Vice President - Marketing and Corporate Communications
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%
地區USD
名稱
營收
佔比
United States
10.93M
83.85%
Europe,Middle East & Africa
1.37M
10.48%
Asia Pacific
671.00K
5.15%
Americas other
68.00K
0.52%
業務
地區
業務USD
名稱
營收
佔比
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
ARCH Venture Partners
15.82%
AWM Investment Company, Inc.
14.37%
First Light Asset Management, LLC
12.93%
State Street Investment Management (US)
6.35%
ARK Investment Management LLC
5.40%
其他
45.13%
持股股東
持股股東
佔比
ARCH Venture Partners
15.82%
AWM Investment Company, Inc.
14.37%
First Light Asset Management, LLC
12.93%
State Street Investment Management (US)
6.35%
ARK Investment Management LLC
5.40%
其他
45.13%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
48.38%
Investment Advisor
21.90%
Venture Capital
15.95%
Individual Investor
8.33%
Hedge Fund
2.27%
Research Firm
1.78%
Pension Fund
0.60%
Bank and Trust
0.09%
其他
0.69%

機構持股

更新時間: 10月5日 週日
更新時間: 10月5日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
224
29.28M
81.15%
-3.78M
2025Q2
226
29.86M
82.76%
-3.27M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
2023Q3
261
30.10M
93.52%
-5.15M
2023Q2
268
30.29M
94.48%
-6.54M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
ARCH Venture Partners
5.73M
15.87%
--
--
Apr 17, 2025
AWM Investment Company, Inc.
5.20M
14.41%
--
--
Jun 30, 2025
First Light Asset Management, LLC
1.07M
2.96%
-633.48K
-37.24%
Jun 30, 2025
State Street Investment Management (US)
2.29M
6.34%
+1.82M
+388.85%
Jun 30, 2025
ARK Investment Management LLC
2.65M
7.34%
-251.07K
-8.66%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.62M
4.48%
+115.41K
+7.69%
Jun 30, 2025
The Vanguard Group, Inc.
1.43M
3.97%
+68.94K
+5.06%
Jun 30, 2025
Knopp (Kevin J)
1.26M
3.5%
+30.00K
+2.43%
May 15, 2025
Brown (Christopher D)
962.12K
2.67%
--
--
Apr 17, 2025
GM Advisory Group, LLC
1.17M
3.23%
+1.17M
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
ARK Genomic Revolution ETF
1.43%
State Street SPDR S&P Kensho Future Security ETF
0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
0.5%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
ARK Genomic Revolution ETF
佔比1.43%
State Street SPDR S&P Kensho Future Security ETF
佔比0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
佔比0.5%
iShares Micro-Cap ETF
佔比0.04%
Avantis US Small Cap Equity ETF
佔比0.02%
iShares Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

908 Devices Inc.的前五大股東是誰?

908 Devices Inc.的前五大股東如下:
ARCH Venture Partners
持有股份:5.73M
佔總股份比例:15.87%。
AWM Investment Company, Inc.
持有股份:5.20M
佔總股份比例:14.41%。
First Light Asset Management, LLC
持有股份:1.07M
佔總股份比例:2.96%。
State Street Investment Management (US)
持有股份:2.29M
佔總股份比例:6.34%。
ARK Investment Management LLC
持有股份:2.65M
佔總股份比例:7.34%。

908 Devices Inc.的前三大股東類型是什麼?

908 Devices Inc. 的前三大股東類型分別是:
ARCH Venture Partners
AWM Investment Company, Inc.
First Light Asset Management, LLC

有多少機構持有908 Devices Inc.(MASS)的股份?

截至2025Q3,共有224家機構持有908 Devices Inc.的股份,合計持有的股份價值約為29.28M,占公司總股份的81.15% 。與2025Q2相比,機構持股有所增加,增幅為-1.61%。

哪個業務部門對908 Devices Inc.的收入貢獻最大?

在FY2025Q2,Device sales revenue業務部門對908 Devices Inc.的收入貢獻最大,創收8.28M,占總收入的63.54% 。
KeyAI